APP is proteolytically cleaved by secretases, resulting in a series of biologically active fragments, including the amyloid-β peptide characterizing the pathogenesis of Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA). The gene discussed is APP; the disease is Alzheimer disease.